These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31551352)

  • 1. Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses.
    Suematsu R; Miyamoto T; Saijo S; Yamasaki S; Tada Y; Yoshida H; Miyake Y
    J Biol Chem; 2019 Nov; 294(45):16776-16788. PubMed ID: 31551352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.
    Angata T; Hayakawa T; Yamanaka M; Varki A; Nakamura M
    FASEB J; 2006 Oct; 20(12):1964-73. PubMed ID: 17012248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion polymorphism of SIGLEC14 and its functional implications.
    Yamanaka M; Kato Y; Angata T; Narimatsu H
    Glycobiology; 2009 Aug; 19(8):841-6. PubMed ID: 19369701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refolded recombinant Siglec5 for NMR investigation of complex carbohydrate binding.
    Barb AW; Wang X; Prestegard JH
    Protein Expr Purif; 2013 Apr; 88(2):183-9. PubMed ID: 23321067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.
    Ali SR; Fong JJ; Carlin AF; Busch TD; Linden R; Angata T; Areschoug T; Parast M; Varki N; Murray J; Nizet V; Varki A
    J Exp Med; 2014 Jun; 211(6):1231-42. PubMed ID: 24799499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14.
    Fong JJ; Sreedhara K; Deng L; Varki NM; Angata T; Liu Q; Nizet V; Varki A
    EMBO J; 2015 Nov; 34(22):2775-88. PubMed ID: 26459514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity ligands of Siglec receptors and their therapeutic potentials.
    Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
    Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes.
    Graustein AD; Horne DJ; Fong JJ; Schwarz F; Mefford HC; Peterson GJ; Wells RD; Musvosvi M; Shey M; Hanekom WA; Hatherill M; Scriba TJ; Thuong NTT; Mai NTH; Caws M; Bang ND; Dunstan SJ; Thwaites GE; Varki A; Angata T; Hawn TR
    Tuberculosis (Edinb); 2017 May; 104():38-45. PubMed ID: 28454648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
    Jones C; Virji M; Crocker PR
    Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viewing Siglecs through the lens of tumor immunology.
    Fraschilla I; Pillai S
    Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
    Murch SH
    Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
    Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
    Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialic acid binding receptors (siglecs) expressed by macrophages.
    Munday J; Floyd H; Crocker PR
    J Leukoc Biol; 1999 Nov; 66(5):705-11. PubMed ID: 10577497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siglec-5 is an inhibitory immune checkpoint molecule for human T cells.
    Vuchkovska A; Glanville DG; Scurti GM; Nishimura MI; White P; Ulijasz AT; Iwashima M
    Immunology; 2022 Jun; 166(2):238-248. PubMed ID: 35290663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialylation pattern in lung epithelial cell line and Siglecs expression in monocytic THP-1 cells as cellular indicators of cigarette smoke - induced pathology in vitro.
    Wielgat P; Trofimiuk E; Czarnomysy R; Holownia A; Braszko JJ
    Exp Lung Res; 2018 Apr; 44(3):167-177. PubMed ID: 29781747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic and clinical immunology of Siglecs.
    von Gunten S; Bochner BS
    Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
    Meril S; Harush O; Reboh Y; Matikhina T; Barliya T; Cohen CJ
    Mol Carcinog; 2020 Jul; 59(7):713-723. PubMed ID: 32391973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.